TipRanks (Thu, 14-Mar 10:15 AM ET)
Anika Therapeutics to reduce workforce by 9%
Seeking Alpha News (Thu, 14-Mar 3:10 AM ET)
Anika Therapeutics Non-GAAP EPS of $0.05 beats by $0.28, revenue of $42.97M beats by $1.57M
Seeking Alpha News (Wed, 13-Mar 4:22 PM ET)
Anika Reports Fourth Quarter and Year-End 2023 Financial Results
Globe Newswire (Wed, 13-Mar 4:05 PM ET)
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire (Fri, 8-Mar 4:01 PM ET)
Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024
Globe Newswire (Tue, 27-Feb 4:01 PM ET)
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States.
Anika Therapeutics trades on the NASDAQ stock market under the symbol ANIK.
As of March 18, 2024, ANIK stock price declined to $25.27 with 101,073 million shares trading.
ANIK has a beta of 0.77, meaning it tends to be less sensitive to market movements. ANIK has a correlation of 0.07 to the broad based SPY ETF.
ANIK has a market cap of $369.73 million. This is considered a Small Cap stock.
Last quarter Anika Therapeutics reported $43 million in Revenue and $.05 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.31.
In the last 3 years, ANIK stock traded as high as $48.37 and as low as $16.54.
The top ETF exchange traded funds that ANIK belongs to (by Net Assets): VTI, IWM, VXF, IWN, DFAT.
ANIK stock has underperformed the market in the last year with a return of -6.1%, while SPY returned +33.9%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ANIK shares. However, ANIK has outperformed the market in the last 3 month and 2 week periods, returning +13.2% and +0.5%, while SPY returned +9.6% and +0.3%, respectively. This indicates ANIK has been having a stronger performance recently.
ANIK support price is $24.63 and resistance is $26.25 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ANIK stock will trade within this expected range on the day.